NCT06421883View on ClinicalTrials.gov

Study the Effect of Probiotic Supplementation on Trimethylamine-N-Oxide Plasma Level in Hemodialysis Patients

PHASE2/PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 15, 2024

Primary Completion Date

June 15, 2024

Study Completion Date

October 15, 2024

Conditions
End Stage Renal Disease
Interventions
DIETARY_SUPPLEMENT

Lactobacillus containing probiotic

"Patients will be randomized into two groups each group includes 40 patients:~Control group: 40 patients will receive their standard therapy only. Intervention group (probiotic group): 40 patients will receive probiotic 5 billion unit per day with their standard therapy for 3 months."

Trial Locations (1)

Unknown

Al Azhar University, Cairo

All Listed Sponsors
lead

Al-Azhar University

OTHER